(Q35180800)

7 August 2017

0 references

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression (English)

1 reference

ORCID Public Data File 2021

7 August 2017

0 references

1 reference

1 reference

1 reference

author name string

Beasley CM Jr

1

1 reference

7 August 2017

Dornseif BE

2

1 reference

7 August 2017

Bosomworth JC

3

1 reference

7 August 2017

Sayler ME

4

1 reference

7 August 2017

Rampey AH Jr

5

1 reference

7 August 2017

Heiligenstein JH

6

1 reference

7 August 2017

Thompson VL

7

1 reference

7 August 2017

Murphy DJ

8

1 reference

7 August 2017

Masica DN

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 1991

1 reference

7 August 2017

1 reference

7 August 2017

303

1 reference

7 August 2017

6804

1 reference

7 August 2017

685-692

1 reference

Development of a Rating Scale for Primary Depressive Illness

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Suicidal feelings in the general population: a prevalence study.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Paradoxical worsening of depressive symptomatology caused by antidepressants

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Panic disorder, comorbidity, and suicide attempts.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Emergence of intense suicidal preoccupation during fluoxetine treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1670974

Suicidal ideation not associated with fluoxetine

13 July 2018

1 reference

12 December 2020

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression

1 reference

12 December 2020

Do some antidepressants promote suicide?

1 reference

12 December 2020

Low-dose fluoxetine therapy for depression

1 reference

12 December 2020

[Recurrence of unipolar depression and efficacy of maprotiline]

1 reference

12 December 2020

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression

1 reference

12 December 2020

Fluoxetine in depressed patients: a comparison with imipramine

1 reference

12 December 2020

A fixed-dose clinical trial of fluoxetine in outpatients with major depression

1 reference

12 December 2020

Pattern analysis of antidepressant response to fluoxetine

1 reference

12 December 2020

Suicidality and fluoxetine: is there a relationship?

1 reference

12 December 2020

Characteristics of responders to fluoxetine

1 reference

12 December 2020

Suicide and Primary Affective Disorders

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.303.6804.685

1 reference

7 August 2017

1 reference

7 August 2017

1 reference